12 December 2024
12 December 2024
The acquisition strengthens Bausch + Lomb's existing portfolio of surgical and pharmaceutical glaucoma treatments.
The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.
The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.
Without knowing more about Trump's plans, it is difficult to predict what effect his second presidency will have on the medical device market.
The five-patient trial of Protaryx’s TSP device took place at Sanatorio Hospital in Paraguay on 3 December.
EndoQuest Robotics’ Endoluminal Surgical (ELS) System is designed to address challenges in endoscopic submucosal dissection procedures.
The test builds upon the MeMed BV test, which assists clinicians in distinguishing between bacterial and viral infections.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
